Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Appropriations

    Back to Income Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Appropriations History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Appropriations ₹9,508 Cr₹8,175 Cr₹7,300 Cr₹6,391 Cr₹5,704 Cr

What is the latest Appropriations of GLENMARK PHARMACEUTICALS ?

The latest Appropriations ratio of GLENMARK PHARMACEUTICALS is ₹9,508 Cr based on Mar2024 Consolidated results.
Year Appropriations
Mar2024₹9,508 Cr
Mar2023₹8,175 Cr
Mar2022₹7,300 Cr
Mar2021₹6,391 Cr
Mar2020₹5,704 Cr

How is Appropriations of GLENMARK PHARMACEUTICALS Trending?

Years Appropriations % Change
Mar2024 ₹9,508 Cr
16.30
Mar2023 ₹8,175 Cr
12.00
Mar2022 ₹7,300 Cr
14.22
Mar2021 ₹6,391 Cr
12.04
Mar2020 ₹5,704 Cr -

Compare Appropriations of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,842.8 Cr 4.8% 5.2% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.9% 1.8% 14% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 5.7% 9.6% 58.6% Stock Analytics
CIPLA ₹121,122.0 Cr -0.8% 1.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,487.0 Cr 0.8% 1.2% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,680.0 Cr 2.9% 6.5% 4.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.8%

5.2%

40%

SENSEX

3.6%

9.5%

13.3%


You may also like the below Video Courses